Results

Vaccine studies

To show its potential and methods/processes we refer to study protocols and summary of ADVANCE proof of concept studies listed on the EU PAS registry.

1. ADVANCE POC-1 Study-Coverage

Testing new approaches to monitoring benefit/risk with pertussis vaccines as test case. Coverage rates of a cellular and whole-cell pertussis-containing vaccines in preschool children.

 Protocol
Report
Publication

2. ADVANCE POC I Study Safety

Testing new approaches to monitoring benefit/risk with pertussis vaccines as test case: Incidence rates of safety outcomes of whole-cell pertussis and acellular pertussis vaccines in pre-school children.

 Protocol
Report
Publication

3. ADVANCE POC 1 Study Benefit

Testing new approaches to monitoring benefit/risk with pertussis vaccines as test case: Incidence rates of pertussis and pertussis related outcomes of whole-cell pertussis and acellular pertussis vaccines in pre-school children.

 Protocol
Report
Publication

4. ADVANCE POC I Benefit-Risk pillar

Testing new approaches to monitoring benefit/risk with pertussis vaccines as test case: benefit-risk analysis of pertussis vaccines in pre-school children comparing whole-cell and acellular formulations in the post-marketing setting

 Protocol
Report
Publication

5. ADVANCE Proof-of-Concept study 1.2

Testing a system for near real-time monitoring of vaccination coverage, benefits and risks in Europe with acellular pertussis vaccines as test case.

 Protocol
No Report
No Publication

6. ADVANCE Proof-of-concept study 2

Exposure and coverage to routine schedule vaccines in different EU countries.

 Protocol
No Report
No Publication